Page last updated: 2024-08-21

indazoles and methotrexate

indazoles has been researched along with methotrexate in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19901 (9.09)18.7374
1990's5 (45.45)18.2507
2000's1 (9.09)29.6817
2010's3 (27.27)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Battelli, T; De Gregorio, M; De Martino, C; Ginnetti, A; Giustini, L; Manocchi, P; Mattioli, R; Silvestrini, B1
Buccheri, G; Ferrigno, D1
Angelini, F; Ausili Cefaro, GP; Blengio, F; Cirulli, S; Cognetti, F; Colella, E; Giannarelli, D; Lo Russo, V; Merlano, M; Scasso, F1
Nardini, S1
Buccheri, G; Ferrigno, D; Rosso, A1
Giovanelli, J; Kaufman, S; Witteveen, CF1
Boccalatte, FE; Bosia, A; Cheng, M; Chiarle, R; Comb, MJ; D'Amico, L; Goss, VL; Inghirami, G; Jensen, ON; Lee, K; Nardone, J; Polakiewicz, RD; Riera, L; Riganti, C; Ruggeri, B; Rush, J; Voena, C1
Baker, LH1
Ito, K; Koike, H; Nishida, Y; Sakai, T1
Italiano, A1
Orbach, D; Penel, N; Ryckewaert, T1

Reviews

1 review(s) available for indazoles and methotrexate

ArticleYear
Non small cell lung cancer and chemotherapy.
    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 1994, Volume: 49, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Fluorouracil; Humans; Indazoles; Lomustine; Lung Neoplasms; Methotrexate; Neoplasm Staging; Treatment Outcome

1994

Trials

3 trial(s) available for indazoles and methotrexate

ArticleYear
A randomised trial of MACC chemotherapy with or without lonidamine in advanced non-small cell lung cancer. Cuneo Lung Cancer Study Group (CuLCaSG)
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:10

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Indazoles; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Survival Analysis

1994
Randomised phase II study of methotrexate (MTX) versus methotrexate plus lonidamine (MTX + LND) in recurrent and/or metastatic carcinoma of the head and neck.
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Indazoles; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local

1994
A phase II study of methotrexate, doxorubicin, cyclophosphamide, and lomustine chemotherapy and lonidamine in advanced non-small cell lung cancer.
    Cancer, 1993, Sep-01, Volume: 72, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Tolerance; Female; Follow-Up Studies; Humans; Indazoles; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Staging; Pilot Projects; Remission Induction; Survival Rate

1993

Other Studies

7 other study(ies) available for indazoles and methotrexate

ArticleYear
A long-term clinical experience with Lonidamine.
    Oncology, 1984, Volume: 41 Suppl 1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Cyclophosphamide; Doxorubicin; Drug Evaluation; Female; Humans; Indazoles; Lomustine; Male; Methotrexate; Middle Aged; Pyrazoles; Tomography, X-Ray Computed

1984
Reduction of quinonoid dihydrobiopterin to tetrahydrobiopterin by nitric oxide synthase.
    The Journal of biological chemistry, 1996, Feb-23, Volume: 271, Issue:8

    Topics: Animals; Arginine; Biopterins; Cell Line; Cerebellum; Enzyme Inhibitors; Humans; Indazoles; Kidney; Kinetics; Methotrexate; NADP; Nitric Oxide Synthase; Nitroarginine; Onium Compounds; Oxidation-Reduction; Rats; Recombinant Proteins; Transfection

1996
The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL.
    Blood, 2009, Mar-19, Volume: 113, Issue:12

    Topics: Amino Acid Sequence; Antimetabolites, Antineoplastic; Carbazoles; Cell Adhesion Molecules; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Profiling; Humans; Hydroxymethyl and Formyl Transferases; Indazoles; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Microfilament Proteins; Molecular Sequence Data; Multienzyme Complexes; Neoplasm Proteins; Nucleotide Deaminases; Phenylurea Compounds; Phosphoproteins; Phosphorylation; Phosphotyrosine; Protein Interaction Mapping; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Transcription, Genetic

2009
The necessity for rigour in rare disease study design.
    The Lancet. Oncology, 2019, Volume: 20, Issue:9

    Topics: Drug Therapy, Combination; Fibromatosis, Aggressive; Humans; Indazoles; Methotrexate; Pyrimidines; Rare Diseases; Research Design; Sulfonamides; Vinblastine

2019
Pazopanib for progressive desmoid tumours: children, persistant effects, and cost.
    The Lancet. Oncology, 2019, Volume: 20, Issue:10

    Topics: Adult; Child; Drug Therapy, Combination; Fibromatosis, Aggressive; Humans; Indazoles; Methotrexate; Pyrimidines; Sulfonamides; Vinblastine

2019
Pazopanib for progressive desmoid tumours: children, persistant effects, and cost - Author's reply.
    The Lancet. Oncology, 2019, Volume: 20, Issue:10

    Topics: Adult; Child; Drug Therapy, Combination; Fibromatosis, Aggressive; Humans; Indazoles; Methotrexate; Pyrimidines; Sulfonamides; Vinblastine

2019
[Systemic treatment for management of aggressive fibromatosis in both adult and children: Level of evidence and unsolved questions].
    Bulletin du cancer, 2020, Volume: 107, Issue:3

    Topics: Adult; Age Factors; Antineoplastic Agents; Child; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cross-Over Studies; Fibromatosis, Aggressive; Humans; Indazoles; Methotrexate; Proof of Concept Study; Protein Kinase Inhibitors; Pyrimidines; Randomized Controlled Trials as Topic; Receptors, Vascular Endothelial Growth Factor; Sorafenib; Sulfonamides; Vinblastine

2020